other material
confidence high
sentiment positive
materiality 0.70
FibroBiologics regains full compliance with Nasdaq listing requirements; monitoring periods imposed
FibroBiologics, Inc.
- Nasdaq confirmed compliance with $2.5M stockholders' equity rule (Mar 9) and $1.00 bid price rule (Apr 17).
- One-year Mandatory Panel Monitor for both equity and bid price; failure during monitor triggers delist determination without cure period.
- Company remains listed on Nasdaq Capital Market under symbol FBLG; all prior listing matters closed.